09.17.25 -- Social Media And A Site-Less Model Lead To Pandemic-Era Success

Learn about this accessible way to understand what HEOR is, how it’s used, and its impact on people and healthcare systems.

This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.

RWE empowers researchers to streamline patient recruitment, choose data-driven trial sites, engage in adaptive trial design, and uncover new treatment possibilities.

What role does Good Clinical Practice (GCP) play in the clinical research ecosystem and how does it safeguard participant rights, safety, and confidentiality while fostering compliance?

From balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions with minimal disruption.

A late-stage biotech developing a first-in-class therapy for a rare, chemo-resistant form of ovarian cancer sought help for accelerated FDA approval.

Understanding patient treatment journeys is paramount. PES offers a comprehensive solution, providing a holistic view of how patients navigate their treatment pathways.

As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.

Learn how you can monitor a large number of cardiac conditions in real-time and support clinical trials across phases and TAs.